The timing of lethality caused by homozygosity for a null allele of the epidermal growth factor receptor (Egfr tm1Mag ) in mice is strongly dependent on genetic background. Initial attempts to genetically map background modifiers using Swiss-derived, outbred CD-1 mice were unsuccessful. To investigate the genetic architecture contributing to survival of Egfr tm1Mag homozygous embryos, the genetic variability segregating within the outbred population was partitioned by surveying viability of Egfr tm1Mag mutants using intercrosses between 129S6/SvEvTAC-Egfr tm1Mag and nine Swiss-derived, inbred strains: ALR/Lt J, ALS/Lt J, APN, APS, ICR/HaRos, NOD/Lt J, NON/Lt J, SJL/J, and SWR/J. The observations showed that these strains support varying levels of survival of Egfr tm1Mag homozygous embryos, suggesting that genetic heterogeneity within the CD-1 stock contributed to the original lack of Egfr tm1Mag modifier detection. Similar to the Swiss-derived intercrosses, nine congenic strains, derived from 129S6/SvEvTAC, AKR/J, APN, BALB/c J, BTBR-T ϩ tf/tf, C3H/HeJ, C57BL/6 J, DBA/2 J, and FVB/N J inbred backgrounds, also supported varying levels of survival of Egfr tm1Mag mutants. By intercrossing the congenic lines to create hybrid F 1 embryos, different genetic backgrounds were found to have complementary modifiers. Analysis of the congenic lines argues against heterosis of outbred backgrounds contributing to Egfr tm1Mag phenotypic variability. A detailed analysis of the crosses suggests that modifiers function at three distinct stages of development. One class of modifiers supports survival of Egfr tm1Mag homozygous embryos to mid-gestation, another class supports development through the mid-gestation transition from yolk-sac to placental-derived nutrient sources, and a third class supports survival through later stages of gestation. Data from microarray analysis using RNA from wildtype and Egfr tm1Mag mutant placentas support the existence of extensive genetic heterogeneity and suggest that it can be molecularly partitioned. This method should be generally useful to partition heterogeneity contributing to other complex traits.
T HE epidermal growth factor receptor (EGFR) is the
; prototypical member of a family of related receptor Riese et al. 1996; Strachan et al. 2001) . The ligands tyrosine kinases (RTKs) that includes ERBB2/NEU, encoded by Egf, Tgf␣, Epgn, and Areg are specific for the ERBB3, and ERBB4 (Carpenter and Wahl 1990; Gul-EGFR, whereas those encoded by Btc, Ereg, and Dtr are lick 1998). Activation of the EGFR results in propagareported to bind either EGFR or ERBB4 with varying tion of extracellular signals into the cytoplasm via activaaffinities (Alroy and Yarden 1997; Riese et al. 1998 ). tion of signaling cascades. These signals, resulting in When misregulated, most RTKs can contribute to develthe alteration of many cellular processes, including proopmental disorders and to pathogenesis, such as cancer. liferation, migration, and differentiation, are initiated Homologous recombination in mouse embryonic by seven known ligands: epidermal growth factor (EGF), stem (ES) cells was previously used to generate a null transforming growth factor ␣ (TGF␣), amphiregulin allele of the Egfr (Threadgill et al. 1995) . Phenotypic (AREG), epiregulin (EREG), betacellulin (BTC), hepaanalysis of mice generated from the targeted ES cells rin-binding Egf/diphtheria toxin receptor (DTR), and revealed that homozygous Egfr tm1Mag null mutants exhibit epigen (EPGN; Cohen 1962; Marquardt et al. 1984;  peri-implantation to postnatal lethality, depending on Ciardiello et al. 1991; Elenius et al. 1991; Higashi- the genetic background of the developing embryo. Consequently, the Egfr tm1Mag null allele was the first targeted mutation to reveal profound variation in survival caused 1 mutant blastocysts form but then die shortly after imand the apparent genetic heterogeneity of the modifiers, a detailed analysis of the underlying genetic archiplantation at 4.5 days post coitus (dpc). These embryos consist of a loosely arranged inner cell mass with no tecture was performed. Genetic heterogeneity was investigated using inbred strains of mice, independently distinct endoderm. In contrast, on Swiss-derived, outbred CD-1 stock, Egfr tm1Mag homozygous pups can survive produced from Swiss-derived, outbred stocks that were assayed for their ability to modify survival of Egfr tm1Mag longer than 3 weeks post-natally, but are severely runted and undergo progressive cerebral degeneration and homozygous offspring through intercrosses and backcrosses with 129S6/SvEvTAC-Egfr tm1Mag heterozygous mice. wasting after birth. Newborn pups, homozygous for the Egfr tm1Mag mutation, can be distinguished from litter-A series of congenic strains containing the Egfr tm1Mag mutation was also created and the resulting Egfr tm1Mag homozymates by waved whiskers and an absence of eyelids, a phenotype similar to mice homozygous for the hypogous mutants were characterized for their stage of lethality. Furthermore, the congenic strains were intercrossed morphic Egfr wa2 allele (Luetteke et al. 1994; Fowler et al. 1995) . On an inbred 129S6/SvEvTAC background, to produce hybrid F 1 mutants to address the genetic complexity of the Egfr modifiers. These studies revealed Egfr tm1Mag homozygous embryos die at 11.5 dpc due to a decreased placental size, compared to littermate concomplex patterns underlying the phenotypic diversity caused by homozygosity for the Egfr tm1Mag mutation, sugtrols, which is caused by a reduced spongiotrophoblast layer and disorganization of the labyrinthine trophogesting that the numbers and interactions between modifiers are extensive and function at three distinct stages blast layer. Surprisingly, on the outbred CD-1 stock, the Egfr tm1Mag homozygous placentas still exhibit a reduced of placental development. To molecularly validate and to investigate a method for partitioning genetic heterospongiotrophoblast layer; however, there is partial rescue of the disorganized labyrinthine trophoblast layer.
geneity, gene expression profiling was performed using microarrays on a subset of placentas. The results reveal Several causes could contribute to the strain-dependent variation observed with survival of Egfr tm1Mag homothat placentas from wild-type embryos are similar while those from different Egfr tm1Mag homozygous embryos manizygous mutants, including differences in background alleles, heterosis, and the maternal uterine environment.
fest highly diverse transcriptional differences. Previous experiments using reciprocal embryo transfers have eliminated the maternal uterine environment as MATERIALS AND METHODS a factor contributing to embryo survival (Threadgill et al. 1995) . Likewise, tetraploid chimeras were used to defini- To investigate the strong genetic-background-depen-
The congenic strains that did not support a robust survival to term of Egfr tm1Mag homozygous embryos were intercrossed to dent phenotypic variation caused by the Egfr tm1Mag allele produce hybrid F 1 backgrounds to test for genome compleMicroarray hybridization: RNA was reverse transcribed to cDNA using an anchored oligo(dT) primer, Cy3 or Cy5 dUTP, mentation. The backgrounds tested include 129S6/SvEvTAC, BALB/c J, C57BL/6 J, and FVB/N J. Embryos were collected and Superscript II RNaseH Ϫ RT enzyme (Invitrogen) at 42Њ for 2 hr. For experimental samples, RNA from wild-type or and genotyped at 13.5 or 18.5 dpc as described above to determine the ability of the combined genomes to support survival Egfr tm1Mag null placenta was labeled with Cy5 and the placental reference RNA was labeled with Cy3. Following reverse tranof Egfr tm1Mag homozygous embryos. Heterozygous 129S6/SvEvTAC-Egfr tm1Mag mice were also mated scription, the mRNA was degraded by addition of NaOH and neutralized with HCl. Cy3-and Cy5-labeled cDNA samples to wild-type mice from nine Swiss-derived, inbred strains, ALR/Lt J, ALS/Lt J, APN, APS, ICR/HaRos, NOD/Lt J, NON/ were combined, free nucleotides were removed, and the samLt J, SJL/J, and SWR/J, to generate F 1 animals heterozygous ples were concentrated and washed with low TE (10 mm Tris for the Egfr tm1Mag allele. Heterozygous F 1 progeny from within pH 7.5, 0.1 mm EDTA pH 8.0) by filtration through a Microeach cross were intercrossed and, only with ALR/Lt J , also backcon-30 filter (Amicon). Samples were collected into an Epcrossed to generate segregating F 2 and N 2 populations, respecpendorf tube and hybridization buffer was added [300 ng tively. At 10.5, 13.5, or 18.5 dpc, embryos were analyzed to yeast tRNA, 600 ng poly(A) RNA, 3ϫ SSC, 0.2% SDS]. Microardetermine the ability of each cross to rescue the mid-gestation ray slides were prehybridized for 45 min in 3ϫ SSC, 0.1% lethality. The homozygous Egfr tm1Mag F 2 embryos were pheno-SDS, 0.2% BSA at 65Њ, washed extensively in ddH 2 O, dipped typed as described for the analysis of the congenic strains.
in isopropanol, and spun at 500 rpm for 5 min to dry. HeatSuccessful female matings were determined by the presence denatured probe samples were added to 7500-gene mouse of copulation plugs with the morning of the plugs designated microarrays prepared by the University of North Carolinaas 0.5 dpc. Pregnant females were euthanized and embryos Chapel Hill Genomics Core and hybridized at 65Њ for 16-20 were dissected from the uterine horns on the morning of 10.5, hr in humidified hybridization chambers (Telechem); mi-13.5, or 18.5 dpc into phosphate buffered saline (PBS). In all croarrays were prepared from 60-mer oligo libraries (Compucrosses the dam is listed first and the sire second unless othergen). The microarrays were washed once in 2ϫ SSC/0.1% wise noted. Mice were fed Purina Mills lab diet 5010 or 5058 SDS for 2 min to remove the coverslips, once in 1ϫ SSC for and water ad libitum under specific pathogen-free conditions 5 min, and twice in 0.1ϫ SSC for 5 min, all at room temperain an American Association for the Accreditation of Lab Aniture with gentle agitation. After centrifugation at 500 rpm for mal Care approved facility. Mice were euthanized by CO 2 5 min at 20Њ to dry, the microarrays were scanned using a asphyxiation.
GenePix 4000B scanner (Axon Instruments, Foster City, CA).
Genotyping:
The placentas and extra-embryonic tissues were A laser detected the individual probes, with the Cy5 probe separated from the embryo by mechanical dissection and eiscanning at 635 nm and pseudocolored red and the Cy3 probe ther whole embryos at 10.5 dpc or pieces of tail from 13.5-detected at 532 nm and pseudocolored green. and 18.5-dpc embryos were collected for DNA extraction to Microarray data analysis and clustering: GenePix Pro 4.0 determine the genotype of individual embryos. DNAs from (Axon Instruments) was used to locate and grid individual these samples were isolated by lysing the tissues in 25 mm spots using the image generated by the scanner. After gridNaOH/0.2 mm EDTA at 95Њ for 20 min. The reaction was ding, the raw fluorescent intensities were collected for each neutralized with an equal volume of 40 mm Tris pH 5.0 and spot and for local background signal. Captured TIFF images centrifuged at 13,000 rpm for 5 min. A total of 200 ng of corresponding to the two fluorescent labels and the raw inten-DNA from each lysis reaction was used to genotype embryonic sity measurements were uploaded into a GeneTraffic v2.5 samples by polymerase chain reaction (PCR) with the folmicroarray database (Iobion). The data were normalized uslowing primers: Egfr25, 5Ј-GCCCTGCCTTTCCCACCATA-3Ј; ing a subgrid Lowess routine and the local background signals Egfr26A, 5Ј-AACGTCGTGACTGGGAAAAC-3Ј; and Egfr27, were subtracted (Yang et al. 2002) . Hierarchical clusters were 5Ј-ATCAACTTTGGGAGCCACAC-3Ј. PCR conditions were as generated with Euclidean distance to the nearest neighbor follows: denaturing at 94Њ, primer annealing at 63Њ, and extento identify groups of genes with similar expression profiles. sion at 72Њ for 40 cycles in a Perkin Elmer (Norwalk, CT) Expression levels across individual samples were represented 9700. PCR products were separated on 1.5% agarose gels; the relative to the median of all samples for each gene. wild-type Egfr allele yields a 350-bp fragment and the targeted Egfr tm1Mag allele a 450-bp fragment detected by ethidium bromide staining. RESULTS Statistical analysis: A one-group chi-square analysis using StatView (SAS Institute) was carried out for all genetic crosses. in the outbred CD-1 stocks. A prediction of this hypothewas isolated from individual 18.5-dpc placentas using 1-2 ml of sis is that independent Swiss-derived, inbred strains trizol (Invitrogen, San Diego) according to the manufacturer's should have partitioned out the genetic heterogeneity protocol. Isolated RNA was quantified using a spectrophotometer and RNA quality analyzed on a Bioanalyzer 2100 (Agilent).
and fixed independent and overlapping sets of modifiers Placental reference RNA was generated by combining 50 g during the inbreeding process. As a consequence, the of total RNA from eight wild-type 18.5-dpc placentas, three Swiss-derived, inbred strains should show a variable abilEgfr tm1Mag 18.5-dpc placentas, four wild-type 17.5-dpc placentas, ity to support embryonic survival of Egfr tm1Mag homozytwo Egfr tm1Mag 17.5-dpc placentas, and one post-natal day (P) 7 and P2 liver.
gous mutants. Nine strains, inbred for various phenotypic characterthat embryos homozygous for the Egfr tm1Mag null mutaistics from Swiss-derived, outbred mouse stocks, were tion, co-isogenic on the 129S6/SvEvTAC genetic backused to test these predictions; included were ALR/LtJ, ground, are viable and present at expected ratios ALS/LtJ, APN, APS, ICR/HaRos, NOD/LtJ, NON/LtJ, through 10.5 dpc, but undergo rapid degeneration SJL/J, and SWR/J (Heston 1963; Crispens 1973;  around 11.5 dpc due to severe placental abnormalities Evans et al. 1974; Casley et al. 1997; Leiter et al. 1998; (Threadgill et al. 1995) . Three groups of intercrosses Graser et al. 1999) . Wild-type mice from each inbred were observed. The first group includes crosses with strain were mated to heterozygous 129S6/SvEvTAC-ICR/HaROS that display poor support for Egfr tm1Mag surEgfr tm1Mag and the resulting F 1 progeny were intercrossed. vival at mid-gestation, worse than that on the co-isogenic The F 2 embryos were phenotyped at 10.5, 13.5, and/or 129S6/SvEvTAC genetic background. Interestingly, in-18.5 dpc (Table 1; Figure 1 ). Previous analysis showed tercrossing with the ICR/HaRos strain produced only 5.3% viable Egfr tm1Mag homozygous embryos at 10.5 dpc, with Egfr tm1Mag homozygous embryos being smaller than either wild-type or heterozygous littermates. The lethality in ICR;129 intercrosses occurs significantly earlier than the Egfr tm1Mag phenotype on the co-isogenic 129S6/ SvEvTAC background, suggesting that ICR/HaRos is a sensitized background, potentially harboring modifiers that result in decreased viability. Although ICR;129 intercrosses support survival of Egfr tm1Mag homozygous embryos better than non-Swiss-derived, outbred CF-1 stock does (Threadgill et al. 1995) , the ICR/HaROS inbred strain may nonetheless have modifiers similar to those in the CF-1 stock.
Crosses with NOD/LtJ, NON/LtJ, and SJL/J repre- lethality observed on the 129S6/SvEvTAC genetic back-ground. Viable NOD;129, NON;129, and SJL;129 F 2 -phen (Casley et al. 1997) . Unlike the other sister strains, viable Egfr tm1Mag homozygous progeny from APS;129 and Egfr tm1Mag homozygous embryos compose 1.5, 0, and 6.6% of the total embryos at 18.5 dpc, respectively. Al-APN;129 intercrosses are present in approximately equal frequencies at 18.5 dpc, composing 12.9 and 11.5% of though there is a statistically significant reduction in the number of viable Egfr tm1Mag homozygous embryos at total embryos, respectively. However, the APS;129 and APN;129 strain combinations, unlike ALR;129 and 13.5 dpc, a subset of these appear capable of surviving until late gestation; the Egfr tm1Mag homozygous embryos ALS;129, show a differential penetrance of surviving Egfr tm1Mag homozygous mutants at mid-gestation, represurviving to late gestation may carry a complete set of modifying genes from the two parental strains. Interestsenting 18.4 and 13.6%, respectively. Nonetheless, viable Egfr tm1Mag homozygous embryos make up 18.4 and ingly, even though NON/LtJ and NOD/LtJ are sister strains that were derived for a difference in susceptibility 18.3% of the total embryos at 13.5 dpc in the nonsister strain combinations APS;129 and ALS;129, respectively. to diabetes, with NON/LtJ being a nondiabetic and NOD/LtJ a diabetic strain (Leiter et al. 1998) homozygous mutants past mid-gestation. of the embryos collected from NON;129 intercrosses were viable Egfr tm1Mag homozygous embryos at 13.5 dpc; The final strain analyzed through intercrosses, SWR/J, was initially derived for an increased susceptibilno viable Egfr tm1Mag homozygous embryos survived to 18.5 dpc in this cross. The observed difference between ity to tumor formation (Heston 1963 Figure 1 ). The SWR/J genetic that better complement those on the 129S6/SvEvTAC background to support survival past mid-gestation and background contains modifiers that support robust survival through mid-gestation, but with reduced survival even to term at a low penetrance.
The remainder of the Swiss-derived, inbred strains during late gestation. Figure 1 ), characterized by a robust ability to support survival of Egfr tm1Mag genic strains: Since extended survival of Egfr tm1Mag homozygous mutants is dependent on genetic background homozygous mutants past the mid-gestation lethality observed on the 129S6/SvEvTAC background. Intercrosses and has been observed only on outbred or mixed backgrounds generated by intercrosses, the inability to gewith ALR/LtJ, ALS/LtJ, APN, APS, and SWR/J all supported viable Egfr tm1Mag homozygous mutants to 18.5 dpc, netically isolate modifiers in crosses using outbred stocks may also have been due to heterosis of the hybrid previously observed only on the outbred CD-1 stock. The ALR;129 intercrosses supported the highest survival backgrounds. To test this possibility, the Egfr tm1Mag mutation was bred onto eight inbred backgrounds, generatof Egfr tm1Mag homozygous mutants, representing 19.7% of the total embryos at 18.5 dpc. Likewise, the sister ing a panel of congenic lines and the original co-isogenic 129S6/SvEvTAC strain. The strains were chosen to maxstrain to ALR/LtJ, ALS/LtJ, also contains modifiers capable of supporting survival past mid-gestation, with imize genetic diversity (Beck et al. 2000) and include 129S6/SvEvTAC, AKR/J, APN, BALB/cJ, BTBR-T ϩ tf/tf, 14.9% of the total embryos being viable Egfr tm1Mag homozygous mutants at 18.5 dpc; ALR/LtJ and ALS/LtJ were C3H/HeJ, C57BL/6J, DBA/2J, and FVB/J. Although we cannot formally exclude some role for derived for their resistance or sensitivity, respectively, to alloxan-induced diabetes (Graser et al. 1999) . However, heterosis, analysis of the Egfr tm1Mag congenic lines also revealed three phenotypic groups arguing against heterin ALR;129 intercrosses, most of the surviving Egfr tm1Mag homozygous mutants at 18.5 dpc were viable, whereas osis playing a significant role in the survival of Egfr tm1Mag homozygous mutants. The three groups of strains, siminonviable Egfr tm1Mag homozygous progeny compose 10% of the total embryos from ALS;129 intercrosses. Interestlar to the groups observed with the intercrosses, include strains that do not support survival past mid-gestation, ingly, ALS/LtJ is more closely related to NON/LtJ than to NOD/LtJ on the basis of allelic similarity at microsathose that show incomplete penetrance of survival past mid-gestation, and those that show high penetrance of tellite repeat polymorphisms (Graser et al. 1999) , and both ALS/LtJ and NON/LtJ are less able than their mutant survival past mid-gestation (Table 2 ; Figure 2 ). The first group of congenic strains, BALB/cJ, BTBR-T ϩ sister strains to support survival of Egfr tm1Mag homozygous mutants. This correlation yields additional support for tf/tf, and FVB/NJ, resemble the phenotype previously described for 129S6/SvEvTAC (Threadgill et al. the segregation of different modifiers from a larger heterogenous pool present in the founder Swiss-derived 1995), with no viable Egfr tm1Mag homozygous embryos surviving to 13.5 dpc. Interestingly, homozygosity for populations, with some inbred strains supporting functional rescue of the Egfr-dependent placental defect Egfr tm1Mag appears to be even more severe on an FVB/NJ background than on the 129S6/SvEvTAC background, much better than other strains.
APS and APN represent a third pair of sister inbred with viable FVB/NJ-Egfr tm1Mag mutant embryos composing only 6.7% of embryos at 10.5 dpc. The FVB/NJ strains derived for differential response to acetamino- results are reminiscent of Egfr tm1Mag survival observed on gous embryos are detected on the C57BL/6J genetic the ICR/HaROS intercross or originally reported for background, which may indicate that placentas from the outbred CF-1 stock (Threadgill et al. 1995) .
Egfr tm1Mag homozygotes can support fetal development On C57BL/6J and DBA/2J genetic backgrounds, to mid-gestation with a low penetrance, but is further representing the second group, viable Egfr tm1Mag homocompromised at some point later during gestation. In zygous embryos are recovered at expected ratios at contrast, on a DBA/2J background 3.4% of the embryos 10.5 dpc, but are greatly reduced by 13.5 dpc composing at 18.5 dpc are viable Egfr tm1Mag homozygotes, similar only 5.3 and 4.3% of the viable embryos at mid-gestation, to the 4.3% frequency observed at mid-gestation. This respectively. By 18.5 dpc, no viable Egfr tm1Mag homozyresult suggests that although the DBA/2J background supports survival of Egfr tm1Mag homozygous embryos only at a low penetrance through mid-gestation, those that do survive will do so to late gestation.
The third group, composed of AKR/J, APN, and C3H/ HeJ backgrounds, supports relatively robust survival past mid-gestation, but is less able to support survival through late gestation. At 18.5 dpc, 6.5, 9.5, and 8.3% of the embryos are viable Egfr tm1Mag homozygous mutants on AKR/J, APN, and C3H/HeJ backgrounds, respectively. However, the surviving Egfr tm1Mag homozygous mutants are runted, exhibit failure of eyelid closure, and have smaller placentas when compared to wild-type littermates.
Despite these differences, occasional Egfr tm1Mag homozygous escapers can be observed. For example, rare ble mutant was observed on the FVB/NJ background Figure 3 ). While combining Egfr tm1Mag homozygous embryos, respectively (Table 3) . the genomes of inbred lines in F 1 hybrids appears to This indicates that the FVB/NJ genome potentially lacks confer the ability to support survival past mid-gestation, or has a reduction in the number or strength of modifialbeit with variable penetrance, not all combinations of ers for late gestation. Potentially, the FVB/NJ genetic genetic backgrounds result in equivalent survival and background may harbor modifiers that exhibit a neganone of the hybrid backgrounds support survival past tive effect on other modifiers of the Egfr tm1Mag homozymid-gestation to the level observed in the outbred CD-1 gous phenotype since FVB/NJ, when congenic for the stocks, suggesting that the alleles carried by these strains Egfr tm1Mag mutation, only partially supports survival to either are not robust modifiers or are insufficient in 10.5 dpc (Table 2) . number to provide complete support for embryonic surRobust, cross-independent recovery of Egfr tm1Mag hovival in the absence of Egfr. mozygous mutants with ALR/LtJ: As an initial step to Although neither the FVB/NJ nor BALB/cJ backidentify modifiers influencing survival of Egfr tm1Mag hogrounds alone support survival of Egfr tm1Mag homozygous embryos past 13.5 dpc (Table 2) , when either background is crossed to the 129S6/SvEvTAC background, embryonic survival is supported at moderate levels past mid-gestation, with all of these embryos surviving to term. FVB129 and BALB129 F 1 -Egfr tm1Mag homozygous embryos represent 8.1 and 13.9% of the total viable embryos at 13.5 dpc, respectively, similar to the numbers surviving at 18.5 dpc (Table 3) . Interestingly, all C57129 F 1 embryos were viable at 13.5 dpc; however, by 18.5 dpc viable Egfr tm1Mag homozygous embryos account for only 10.9% of the total embryos (Table 3) , a reduction of ‫%05ف‬ over the total number of Egfr tm1Mag homozygous embryos observed.
Viable Egfr tm1Mag homozygous embryos of FVBBALB F 1 hybrids account for 12.1% of the total embryos at 13.5 dpc, similar to that observed when either strain is mozygous embryos using inbred strains and bypassing two genotypic groups molecularly confirmed the existence of extensive genetic heterogeneity across individthe genetic heterogeneity present in outbred stocks, ALR129 F 1 -Egfr tm1Mag mice were intercrossed or backual placentas and indicates that microarrays will be a generally useful tool for partitioning genetic heterogecrossed to 129S6/SvEvTAC-Egfr tm1Mag mice to generate ALR;129 F 2 and N 2 progeny, respectively, ostensibly segneity contributing to complex traits. After normalization, 4462 valid probes were retained regating ALR/LtJ-derived loci contributing to the robust survival observed with this genetic background (Taacross all eight hybridizations, revealing interesting trends after hierarchical clustering of the data from bles 1 and 4). Although only 11% were viable Egfr tm1Mag homozygous embryos in the backcrosses, roughly half each placenta ( Figure 4A ). While variation across wildtype placentas was observed, the extent and levels of that observed in the intercrosses, no statistically significant reduction in the total number of Egfr tm1Mag homozyvariation are significantly less than that observed across the Egfr tm1Mag homozygous placentas. The significant gous progeny was observed at 18.5 dpc, with 22-25% of the recovered embryos being homozygous for Egfr tm1Mag gene expression variation observed across the individual placenta from Egfr tm1Mag homozygous embryos suggests in all crosses. The nonviable Egfr tm1Mag homozygous mutants at 18.5 dpc had died within a day or two prior to that not all Egfr tm1Mag homozygous placentas are molecularly similar. This supports the genetic data indicating collection. These results suggest that the ALR/LtJ genome has captured multiple survival modifiers for Egfr tm1Mag that the Egfr tm1Mag modifiers are genetically heterogeneous and that survival of Egfr tm1Mag homozygous emmutants from the genetic heterogeneity originally detected in the outbred CD-1 stocks. These alleles need bryos is due to differential segregation of a heterogeneous group of modifying genes. Even with these limited to be partitioned further via subsequent backcrossing or alternative approaches to efficiently identify individdata, it appears that there are at least two major classes of Egfr tm1Mag homozygous placentas at 18.5 dpc: those ual or groups of modifiers capable of altering survival of Egfr tm1Mag homozygous mutants. that are more similar to the wild-type placental gene profile ( Figure 4A , samples 4-5) and those that show Molecular heterogeneity of Egfr tm1Mag modifiers revealed by microarray analysis: Microarray technology, widely more divergence in gene expression ( Figure 4A , samples 6-8). used to distinguish tumor classes on the basis of global similarities to steady-state differences in cellular tranThe eight hybridizations were further analyzed by sampling only those genes with a twofold or greater script levels (DeRisi et al. 1996; Perou et al. 1999; Rickman et al. 2001) , was used to investigate the genetic change in gene expression across all valid spots, resulting in 141 genes meeting the more stringent criteria heterogeneity associated with the number and intensity of modifying alleles segregating in the ALR;129 crosses.
( Figure 4B ). Similar to the entire data set, the 141 genes in the three wild-type samples were generally more simiFor the microarrays, total placental RNA was extracted from viable 18.5 dpc wild-type and Egfr tm1Mag homozygous lar in expression than those in the five Egfr tm1Mag homozygous placentas with greater heterogeneity noted embryos and compared to a common reference RNA. The placental samples were obtained from N 2 embryos, across the Egfr tm1Mag homozygous samples. Gender of the embryos did not influence the clustering results (data produced by backcrossing ALR129 F 1 -Egfr tm1Mag females to 129S6/SvEvTAC-Egfr tm1Mag males such that individual not shown). Likewise, littermates did not cluster together, suggesting that the observed molecular profiles samples would be segregating heterogeneous ALR/LtJderived alleles capable of modifying survival of Egfr tm1Mag are dependent on the alleles carried by the individual placental samples. homozygous embryos.
Gene expression profiles using placental RNA from five individual Egfr tm1Mag homozygous and three wild-DISCUSSION type matched littermate controls were analyzed to reveal numerous differentially expressed genes between wildThe placenta is a highly specialized yet transitory organ necessary for nutrient and waste exchange between type and Egfr tm1Mag homozygous placentas (Figure 4) . Furthermore, the level of individual variation across the the mother and the developing fetus in mammals and is composed of multiple cell types, including mesenchy-C3H/HeJ, C57BL/6J, DBA/2J, and FVB/NJ, developed into congenics. Most of the Swiss-derived strains mal cells, endothelial cells of the labyrinthine vascularature, hormone-secreting and glycogen cells of the sponhave the ability, at least partially, to support survival of Egfr tm1Mag homozygous mutants through mid-gestation, giotrophoblast, and trophoblast giant cells. Given the diverse roles of the various cell types in the placenta, while more distantly related strains, like AKR/J, APN, and C3H/HeJ, and to a lesser extent DBA/2J, also have variability in lethality of Egfr tm1Mag homozygous mutants may be caused by functional differences in hormone this ability. Although many Swiss-derived strains modify the mid-gestation lethality similarly, the data in their production, cytokine signaling, transcription factors, cell cycle regulation, and growth factor signaling in one entirety suggest that there are differential effects of modifying genes segregating among the various genetic or more cell types.
One possible mechanism to explain the variable phebackgrounds (Table 5 ). Our data also suggest that EGFR is required at three distinct stages of development: prior notypes observed with Egfr tm1Mag homozygous embryos is heterosis. However, the current results do not support to mid-gestation, at mid-gestation, and during late gestation ( Figure 5 ). Various combinations of overlapping this mechanism as heterosis cannot explain the reduced survival of Egfr tm1Mag homozygous embryos from NON;129 or independent modifiers likely act at critical stages throughout gestation and contribute to the genetic hetand ICR;129 intercrosses. If heterosis were to account for the ability to rescue the mid-gestation lethality and erogeneity observed in previous attempts to map modifiers of the Egfr tm1Mag homozygous phenotype. the inability to genetically map specific modifiers, one would expect a uniform rescue across various hybrid
The ICR/HaRos and FVB/NJ backgrounds resemble the outbred CF-1 background in that the embryo is backgrounds, which was not observed in this study. Furthermore, since Egfr tm1Mag homozygous embryos can suralready compromised prior to the switch from yolk sac to the placental-mediated nutrient exchange that occurs vive, albeit at a low penetrance, to birth on the inbred AKR/J, APN, C3H/HeJ, and DBA/2J genetic backat mid-gestation. The FVB/NJ strain, a Swiss-derived strain, appears to exhibit the same inability to support grounds (Table 2) , homozygosity is sufficient to support survival providing the optimal combination of alleles is Egfr tm1Mag homozygous embryo survival that is observed with ICR;129 intercrosses, but not as severely as the nonpresent. Likewise, the Egfr tm1Mag null mutation on a nonSwiss-derived, outbred CF-1 background is peri-implanSwiss-derived, outbred CF-1. This indicates that the first critical window for the EGFR activity during developtation lethal at e4.5, which is earlier than would be expected if heterosis was responsible for the genetic ment occurs prior to 10.5 dpc. Since, the Egfr tm1Mag mutation on FVB/NJ and ICR/HaRos backgrounds cannot variation observed.
A much more likely explanation for Egfr tm1Mag phenosupport survival to mid-gestation, they either lack specific modifying alleles or have strong suppressor alleles. typic variability is through the action of modifier genes. Two groups of strains were used in this study to investiFurthermore, of the parental strains not supporting survival past mid-gestation, the BALB.129 and FVB.129 F 1 gate the genetic architecture of Egfr tm1Mag modifiers: the Swiss-derived strains, ALR/LtJ, ALS/LtJ, APN, APS, hybrids most effectively rescue the placental mid-gestation lethality. However, combinations of FVB/NJ and ICR/HaRos, NON/LtJ, NOD/LtJ, SWR/J, and SJL/J, in intercrosses and a panel of genetically diverse strains, BALB/cJ show a reduced ability to rescue the mid-gestation lethality. These observations suggest that the FVB/NJ 129S6/SvEvTAC, AKR/J, APN, BALB/cJ, BTBR-T ϩ tf/tf, Prior to mid-gestation Mid-gestation After mid-gestation Strain Group a (4.5-9.5 dpc) (10.5-13.5 dpc) (14.5-18.5 dpc) and BALB/cJ genetic backgrounds contain similar overembryos at 13.5 dpc. Given the robust and highly heterogeneous composition of Egfr tm1Mag homozygous modifilapping and noncomplementing alleles modifying midgestation survival.
ers in Swiss-derived, outbred mice, it is not surprising that during the process of inbreeding, most strains capThe second critical window for EGFR activity occurs at mid-gestation when the placenta replaces the yolk sac tured alleles that support survival of Egfr tm1Mag homozygous embryos at some level through mid-gestation. The as the primary mediator of nutrient and waste exchange. Most of the strains tested are able to survive, at least with alleles involved in modifying the Egfr tm1Mag homozygous phenotype appear to be numerous and since they also reduced penetrance, past mid-gestation. Combinations among ALR/LtJ, ALS/LtJ, APN, and APS and 129S6/ confer an increase in fecundity via increases in viability, they may have been inadvertently selected for during SvEvTAC as well as AKR/J, APN, and C3H/HeJ and, to a lesser extent, C57BL/6J, DBA/2J, NOD/LtJ, SJL/J, the derivation of the Swiss-derived, inbred strains. The third window for activity of Egfr tm1Mag modifiers and SWR/J, all support viable Egfr tm1Mag homozygous Figure 5 .-Schematic of embryonic lethality of Egfr tm1Mag homozygous mutants. The time line depicts when the majority of Egfr tm1Mag homozygous embryos on specific strains are affected by modifying alleles. Group 1 strains primarily die prior to mid-gestation, group 2 at mid-gestation, and group 3 during late gestation. occurs between 13.5 and 18.5 dpc of gestation. For influenced by, the segregation of genes that modify the Egfr tm1Mag placental phenotype. ALR;129, ALS;129, APS;129, APN;129, and SJL;129 intercross progeny homozygous for Egfr tm1Mag as well as the The role of EGFR during placental development is proving to be complex, and the EGFR-deficient phenocongenic APN and DBA/2J strains, it appears that if the embryos can live past 13.5 dpc, then they will survive type has the potential for being modified by many genes. Since the phenotypic consequences of Egfr tm1Mag phenoto term. The comparable numbers of viable embryos observed at 13.5 and 18.5 dpc for each of these strains type modification can be attributed to many genes segregating within individual animals, their detection has recompared to strains with similar survival at 13.5 dpc but with dramatically reduced survival at 18.5 dpc, like mained elusive. Furthermore, the variation in the Egfr tm1Mag homozygous phenotypes may be attributed to AKR/J, C3H/HeJ, and SWR;129 intercrosses, further support the hypothesis for a third critical window during the presence of many interchangeable modifier variants with strong effects or to larger groups of genes, with development when the EGFR is needed.
Currently the dissection of complex traits has moved each gene having only a small effect on the Egfr tm1Mag phenotype. When all of these genes are combined in the to the forefront of genetics with many disease processes being controlled or influenced by complex genetic inappropriate context, the resulting genetic complement has a synergistic effect on the Egfr tm1Mag homozygous teractions. The experiments with Egfr tm1Mag homozygous phenotypes are complicated by the fact that the quantiphenotype. The genetic studies presented here support the existence of multiple genes of varying strength that tative variable is the time of embryonic survival. Consequently, this trait requires the use of alternative methods can modify the Egfr tm1Mag homozygous phenotype. The current results also have significant implications for identifying the modifier genes. Microarray technology is one method that has been used frequently to parfor various disease states. For example, aberrant EGFR signaling has been implicated in intrauterine growth tition genetic heterogeneity using the relative change in gene expression between samples ( Jansen and Nap retardation (IUGR) and in cancer (Dassonville et al. 1993; Rusch et al. 1993; Fondacci et al. 1994 Modifying genes that compensate for EGFR loss in the subclasses of mutants that possess similar or identical sets of modifiers that segregate in an otherwise heterogeEgfr tm1Mag homozygous mutants may also contribute to resistance to anti-EGFR therapy. Consequently, it is probneous background. Analysis of many samples may permit the partitioning of the Egfr tm1Mag homozygous surviable that EGFR inhibitors currently being evaluated in human clinical trials will have highly variable rates of vors into distinct molecular classes; these individual classes can then be potentially linked through classical success that are determined by an individual patient's genetic background and the EGFR modifying alleles that quantitative trait analysis to specific genomic regions modifying the placental phenotype. Preliminary analysis of they harbor. Similarly, the Egfr tm1Mag -modifying genes present in mouse strains may provide useful diagnostic five Egfr tm1Mag homozygous placentas shows variation in gene expression across individual placentas, consistent markers and therapeutic targets to treat IUGR and to identify patients that will respond to anti-EGFR therapy. with a heterogeneous modification at the molecular level.
There are limits to the information that can be mined that it is likely that the variation observed is due to, or
